Latest filing published 03 Jan 2019 for Protara Therapeutics, Inc., €4,130.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -2.4%Entry US$68.00 · Close at T+365 US$66.40
- -78.3%Entry US$230.00 · Close at T+365 US$50.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
George Arthur Eldridge: trading record in brief
All filings by George Arthur Eldridge on record concern Protara Therapeutics, Inc. We count 9 filings; the first trade dates from 6 June 2016 and the latest from 31 December 2018.
The open-market record is one-sided, with 5 purchases worth €21k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 4 share grants.
The median purchase comes to €2,154. The 5 purchases reviewed show no overlap with other insiders buying the same stock within a month. After 5 purchases with a full 90-day history, the hit rate stands at 100% and the median 90-day move at +59.0%. These figures describe past trades and do not predict future prices.
Most recently, on 3 January 2019, the filings show a share grant worth €4,130 in Protara Therapeutics, Inc. The most recent open-market purchase was published on 14 November 2017, 3,282 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to George Arthur Eldridge
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,448 shares@ US$1.9318.4% of flowCommon StockSEC:0001171843-19-000064:0
- 10,000 shares@ US$1.6241.0% of flowCommon StockSEC:0001171843-18-004989:0
- 3,934 shares@ US$1.307.9% of flowCommon StockSEC:0001171843-18-000082:0
- 295 shares@ US$1.690.8% of flowCommon StockSEC:0001171843-17-007021:0Canonical exit: 12 Feb 2018 (T+90)
- 10,000 shares@ US$1.3020.8% of flowCommon StockSEC:0001171843-17-003952:0
- 2,750 shares@ US$5.7825.6% of flowCommon StockSEC:0001171843-16-010533:0Canonical exit: 4 Sept 2016 (T+90)
- 425 shares@ US$5.763.9% of flowCommon StockSEC:0001171843-16-010533:1Canonical exit: 4 Sept 2016 (T+90)
- 425 shares@ US$5.784.0% of flowCommon StockSEC:0001171843-16-010533:2Canonical exit: 4 Sept 2016 (T+90)
- 400 shares@ US$5.783.7% of flowCommon StockSEC:0001171843-16-010533:3Canonical exit: 4 Sept 2016 (T+90)
9 of 9 declarations
